Navigation Links
Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
Date:4/14/2008

profile with reduced gastrointestinal and hematopoietic

toxicity compared to irinotecan with repeat dosing in dogs"

#5742: "NKTR-102, a novel PEGylated-irinotecan, has a superior acute

safety, tolerability, and pharmacokinetic profile compared to irinotecan

in rats and dogs"

Prior data presentations on the anti-tumor activity and pharmacokinetics of NKTR-102 in mouse xenograft models of colorectal, breast and lung cancer can be found at http://www.nektar.com/wt/page/nktr102media.

About NKTR-102

Nektar is developing NKTR-102, a PEGylated form of irinotecan, which was invented by Nektar using its world-leading small molecule PEGylation technology platform. The product is currently in Phase 2 clinical development. Irinotecan is an important chemotherapeutic agent used for the treatment of solid tumors, including colorectal and lung cancers. By applying Nektar's small molecule PEGylation technology to irinotecan, NKTR-102 may prove to be a more powerful and tolerable anti-tumor agent. Preclinical studies show that treatment with NKTR-102 results in significant suppression of tumor growth in an irinotecan-resistant mouse colorectal tumor model and in similar models of breast and lung cancer. Administration of NKTR-102 in an animal model also results in a markedly improved time-concentration profile for SN38, the active metabolite of irinotecan, as compared to treatment with irinotecan.

Nektar PEGylation Platform

Nektar PEGylation technology can enhance the properties of therapeutic agents by increasing drug circulation time in the bloodstream, decreasing immunogenicity and dosing frequency, increasing bioavailability and improving drug solubility and stability. It can also be used to modify pharmaceutical agents to preferentially target certain systems within the body. It is a technique in which non-toxic polyethylene glycol (PEG) polyme
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
6. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
7. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
8. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
9. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
10. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
11. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014 In September ... Performance Scrubs carried out a new product development plan ... very first "limited edition" lab coat , aptly ... professors of surgery in the world. The new women,s ... unisex predecessors, with a sleek envelope collar, vertical princess ...
(Date:11/21/2014)... SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ ... industrial hemp containing low THC, announces they are now ... is comparable to Charlotte,s Web type strains grown in ... symptoms from other neurological disorders, such as Parkinson,s, MS, ... waiting for US laws to pass, because imported CBD ...
(Date:11/21/2014)... CITY, Calif. , Nov. 21, 2014  Abaxis, ... company manufacturing point-of-care instruments and consumables for the medical, ... services to the veterinary and research markets in ... completion of a stock purchase agreement to acquire 100% ... United Kingdom based distribution organization. The transaction ...
Breaking Medicine Technology:Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... (Nasdaq: STXS ) announced today financial results for ... with the preliminary results reported on October 13, 2010. Third ... and reductions in both operating loss and net loss. ... compared to $13.3 million in the third quarter 2009. As ...
... Quality Forum (NQF) announces the election of leadership ... NQF is a unique, multi-stakeholder, nonprofit ... healthcare by setting national priorities and goals for ... and publicly reporting on performance, and promoting the ...
Cached Medicine Technology:Stereotaxis Reports Third Quarter Financial Results 2Stereotaxis Reports Third Quarter Financial Results 3Stereotaxis Reports Third Quarter Financial Results 4Stereotaxis Reports Third Quarter Financial Results 5Stereotaxis Reports Third Quarter Financial Results 6Stereotaxis Reports Third Quarter Financial Results 7National Quality Forum Members Elect New Council Leaders 2
(Date:11/24/2014)... 2014 Gersowitz Libo & Korek, P.C., a ... national Tier recognition in the 2015 Edition of U.S. News-Best ... signals a unique combination of quality law practice and breadth ... this honor and especially grateful to our clients whose continued ... ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/23/2014)... a well-known wedding dress manufacturer, has unveiled its new collection ... now offered at deeply discounted prices, up to 75 percent ... 15. The main purpose of the promotion is to expand ... are ideal options for ladies who are eager to look ... new mint cocktail dresses are very beautiful; they are made ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water ... providing an 8 year warranty on its selected hot water ... up due to the impending winter season, it was important ... premium service that the company provides. As a result, Pro ... Wood and Bradford hot water tanks. , “Every installer ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released a ... are available at low rates up to 30% off. ... new emergency doors. The emergency door adopts fireproof material ... several colors. All of the products are top-quality guaranteed. ... not as easy as many people think. As ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 More than ... month in a federal litigation involving Byetta lawsuits ( ... medications, Bernstein Liebhard LLP reports. , A Case ... over a class of Type 2 diabetes medications referred ... the U.S. District Court, Southern District of California, where ...
Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... President, Corporate Development and, Senior Vice ... N.J., Sept. 11 Pharmacopeia,(Nasdaq: PCOP ), ... novel,small molecule therapeutics, today announced the appointments of ... and S. David,Kimball, Ph.D., as Senior Vice President, ...
... 11 Vista Partners announced today,that it has ... ).,Ross Silver, Director of Research for Vista Partners ... I trials. We were,particularly encouraged by activity in ... been approved for use in this difficult to ...
... XI,AN, China, Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- China,Bionanometer Industries ... the bionanometer industry, has recently promoted a new,series ... a year of scientific verification, research and experiments. ... dream, and therefore the product,line,s name means -- ...
... Health Card Systems, Inc. (Nasdaq: NMHC ), a ... for the fiscal,fourth quarter and fiscal year ended June ... Revenue for the 2007 fiscal fourth quarter was ... the same period last year, a 31.0,percent decrease. This ...
... Stop Severe Bleeding, BETHESDA, Md., Sept. 10 ... high-pressure,bleeding in moderate to severe wounds has received FDA ... good news for soldiers,and civilians alike, because the product ... spot. "The FDA,s speedy approval of WoundStat means ...
... Sept. 10 The Blue Cross and Blue,Shield ... Department of Health Care Policy, announced today seven ... BlueWorks(R) winners, in the,category of ,Collaborating with Providers., ... the Harvard Medical School,Department of Health Care Policy ...
Cached Medicine News:Health News:Pharmacopeia Announces Senior Additions to Management Team 2Health News:Pharmacopeia Announces Senior Additions to Management Team 3Health News:Pharmacopeia Announces Senior Additions to Management Team 4Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 3Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 5Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 6Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 7Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 8Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 9Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 10Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 11Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 12Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 13Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 14Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 15Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 16Health News:Life-Saving News for Battlefield Soldiers & Wounded Civilians 2Health News:Life-Saving News for Battlefield Soldiers & Wounded Civilians 3Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 2Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 3Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 4Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 5
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... closed dilution nebulizer allows the clinician to deliver ... gas into the side port for precise high ... P31000N, for normal flow patients, delivers 8-12 lpm ... the side port. For your high flow needs, ...
... For use with metered dose inhalers., ... aerosolized medication from MDI canisters. Its versatile ... a ventilator circuit, in conjunction with an ... routine, oral inhalation. ACE may also be ...
Rotary Piston Mini Nebulizer...
Medicine Products: